Heartbeam Inc (BEAT)

Currency in USD
0.810
-0.029(-3.45%)
Closed·
0.825+0.015(+1.80%)
·
BEAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.8050.863
52 wk Range
0.5404.000
Key Statistics
Prev. Close
0.839
Open
0.858
Day's Range
0.805-0.863
52 wk Range
0.54-4
Volume
568.55K
Average Volume (3m)
1.48M
1-Year Change
-50.9091%
Book Value / Share
0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BEAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.833
Upside
+373.25%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Heartbeam Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.833
(+373.25% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy2.50+208.64%5.50MaintainMay 22, 2026
Benchmark
Buy5.00+517.28%8.00MaintainMay 15, 2026
D. Boral Capital
Hold---DowngradeApr 20, 2026
B.Riley
Buy4.00+393.83%-New CoverageMar 31, 2026
D. Boral Capital
Buy5.00+517.28%-New CoverageMar 27, 2026

Heartbeam Inc Earnings Call Summary for Q1/2026

  • HeartBeam reported Q1 2026 EPS of -$0.12, beating forecast of -$0.14 by 14.29%; stock surged 11.89% after-hours to $0.944.
  • Company secured $11.5M financing in April 2026, boosting pro forma cash position to $12.4M and extending operational runway significantly.
  • Revised 2026 cash outflow guidance to below $16M from prior $17-19M range; Q1 operating cash burn decreased 19% year-over-year to $3.6M.
  • Net loss totaled $4.7M for Q1 2026 as company advances 12-lead ECG technology while maintaining lean commercial team structure.
  • Management expressed confidence in strategic partnerships and product innovation; ongoing FDA discussions critical for approval timeline and market adoption.
Last Updated: 05/14/2026, 05:36 AM
Read Full Transcript

Earnings

Latest Release
May 13, 2026
EPS / Forecast
-0.12 / -0.14
Revenue / Forecast
100K / 99.87K
EPS Revisions
Last 90 days

BEAT Income Statement

Compare BEAT to Peers and Sector

Metrics to compare
BEAT
Peers
Sector
Relationship
P/E Ratio
−2.2x−1.7x−0.5x
PEG Ratio
−0.09−0.190.00
Price/Book
68.6x4.6x2.6x
Price / LTM Sales
-4.5x3.0x
Upside (Analyst Target)
376.8%104.9%58.6%
Fair Value Upside
Unlock20.4%10.2%Unlock

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.35M4.39%1.98M
Other Institutional Investors
7.28M13.57%6.10M
Public Companies & Retail Investors
44.00M82.04%36.91M
Total
53.63M100.00%44.99M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Strome Investment Management, L.P.6.34%3,400,0002,852
Vanguard Index Funds - Vanguard Total Stock Market ETF2.70%1,448,4021,215

People Also Watch

29.1300
ASTC
-13.04%
237.98
CBRS
+18.39%
24.300
MRAM
+2.71%
18.565
RDW
+0.62%
4.0600
SIDU
-3.56%

FAQ

What Is the Heartbeam (BEAT) Stock Price Today?

The Heartbeam stock price today is 0.810 USD.

What Stock Exchange Does Heartbeam Trade On?

Heartbeam is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Heartbeam?

The stock symbol for Heartbeam is "BEAT."

What Is the Heartbeam Market Cap?

As of today, Heartbeam market cap is 44.990M USD.

What Is Heartbeam's Earnings Per Share (TTM)?

The Heartbeam EPS (TTM) is -0.563.

When Is the Next Heartbeam Earnings Date?

Heartbeam will release its next earnings report on Aug 06, 2026.

From a Technical Analysis Perspective, Is BEAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Heartbeam Stock Split?

Heartbeam has split 0 times.

How Many Employees Does Heartbeam Have?

Heartbeam has 16 employees.

What is the current trading status of Heartbeam (BEAT)?

As of Jun 08, 2026, Heartbeam (BEAT) is trading at a price of 0.810 USD, with a previous close of 0.839 USD. The stock has fluctuated within a day range of 0.805 USD to 0.863 USD, while its 52-week range spans from 0.540 USD to 4.000 USD.

What Is Heartbeam (BEAT) Price Target According to Analysts?

The average 12-month price target for Heartbeam is 3.833 USD, with a high estimate of 5 USD and a low estimate of 2.5 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +373.25% Upside potential.

What Is the BEAT Premarket Price?

BEAT's last pre-market stock price is 0.840 USD. The pre-market share volume is 23,840.000, and the stock has decreased by 0.001, or 0.120%.

What Is the BEAT After Hours Price?

BEAT's last after hours stock price is 0.825 USD, the stock has decreased by 0.015, or 1.800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.